🍪 Cookies

We use cookies to store, access and process personal data to give you the best online experience. By clicking Accept Cookies you consent to storing all cookies and ensure best website performance. You can modify cookie preferences or withdraw consent by clicking Cookie Settings. To find out more about cookies and purposes, read our Cookie Policy and Privacy Notice.

Cookies settings


Cookie Control

What are cookies?

Cookies are small text files that enable us, and our service provides to uniquely identify your browser or device. Cookies normally work by assigning a unique number to your device and are stored on your browser by the websites that you visit as well as third-party service providers for those website. By the term cookies other technologies as SDKs, pixels and local storage are to be considered.


If Enabled

We may recognize you as a customer which enables customized services, content and advertising, services effectiveness and device recognition for enhanced security
We may improve your experience based on your previous session
We can keep track of your preferences and personalize services
We can improve the performance of Website.


If Disabled

We won't be able to remember your previous sessions, that won't allow us to tailor the website according to your preferences
Some features might not be available and user experience reduced without cookies


Strictly necessary means that essential functions of the Website can not be provided without using them. Because these cookies are essential for the properly working and secure of Website features and services, you cannot opt-out of using these technologies. You can still block them within your browser, but it might cause the disfunction of basic website features.

  • Setting privacy preferences
  • Secure log in
  • Secure connection during the usage of services
  • Filling forms

Analytics and performance tracking technologies to analyze how you use the Website.

  • Most viewed pages
  • Interaction with content
  • Error analysis
  • Testing and Measuring various design effectivity

The Website may use third-party advertising and marketing technologies.

  • Promote our services on other platforms and websites
  • Measure the effectiveness of our campaigns

Trader's Diary

Economic calendar

Jun
2025
Definition of terms:
Earnings
IPOs
Splits
Week 24

Moderna updated their COVID vaccine

Date: 6.9.2023

Despite Covid has been almost forgotten, it reappeared in many countries in Europe. So even if we thought that it is finally over, the sad reality is that the virus is still among us. I decided to check pharmaceutical companies that produce Covid vaccines if they have any news. I was not left disappointed, as article on Reuters provided me information about Moderna updating their vaccine.

Article said that Moderna announced that clinical trial data indicates its revised COVID-19 vaccine is likely to be effective against the highly-mutated BA.2.86 subvariant of the coronavirus, which has raised concerns about a potential resurgence of infections. The vaccine demonstrated an 8.7-fold increase in neutralizing antibodies against BA.2.86 in human trials, a variant closely monitored by health organizations. Moderna's infectious diseases head, Jacqueline Miller, stated that this news should encourage people to consider fall booster shots and provide reassurance to regulators. The U.S. Food and Drug Administration is expected to approve the updated vaccine later this month or in early October. Other vaccine manufacturers like Pfizer and Novavax have also developed shots targeting specific subvariants of the virus, indicating an ongoing effort to combat evolving strains. Despite the spread of BA.2.86, global vaccination and immunity from prior infections are expected to mitigate the risk of severe disease and death associated with this variant.

Among good news about Moderna, there were also reports about Pfizer and Novavax. It is said that the drug manufacturer based in Massachusetts, along with competing COVID-19 vaccine producers Novavax and Pfizer in partnership with German firm BioNTech, have developed modified versions of their vaccines specifically targeted at the XBB.1.5 subvariant.

Because of the fact that Moderna stocks had the biggest surge during the pandemic, I have decided to check them again, if there is a possibility of new Covid pandemic around the world. Pre-pandemic price of stocks was at around 20 USD, while the highest point it reached was in 2021, when the price peaked to 450 USD.* This marks an unbelievable growth of more than 2,000%.* In hopes that stock can make a similar performance, I have decided to invest smaller amount and wait. [1]

Slika1

Movement of Moderna stocks in the last five years. (Source: Investing) *

* Past performance is no guarantee of future results.

[1] Forward-looking statements are based on assumptions and current expectations, which may be inaccurate, or based on the current economic environment which is subject to change. Such statements are not guaranteeing of future performance. They involve risks and other uncertainties which are difficult to predict. Results could differ materially from those expressed or implied in any forward-looking statements.

Date: 26.2.2025
Super Micro Averts the Threat of Delisting and Rises Sharply

After analyzing the quarterly results of Super Micro Computer Inc. (NASDAQ: SMCI), I noticed a sharp increase in the price of their shares. In extended trading, they rose by about 22% after the company filed its late financial statements on time to meet the Nasdaq exchange's requirements to remain in the index. The move removed the threat of delisting that hung over the firm due to financial reporting issues and the loss of an auditor in 2023. At the same time, Super Micro announced that the new BDO auditor confirmed the compliance of the results with GAAP accounting principles, which managed to stabilize the situation. What awaits us next?

Date: 19.2.2025
Intel and Speculation About a Possible Company Split

Today, I noticed that Intel's stock has risen by nearly 50% from its February low, clearly indicating that the price is reacting to ongoing speculation about a potential company split.* Intel has been struggling with the loss of its technological edge and market share, with its performance lagging behind competitors like Nvidia, which dominates the AI chip segment. Ongoing negotiations between TSMC, Broadcom, and the Silver Lake investment group suggest that Intel's leadership is actively exploring ways to regain its market position and restore investor confidence.

Date: 12.2.2025
Alibaba and Apple Forge AI Partnership in China

This morning, I noticed a sharp increase in Alibaba shares – almost 8%1 since last week. The stock thus continues the bullish trend that we last saw in September last year.* I immediately started to find out what was behind it, and I came across an interesting piece of news. Apple is reportedly working with Alibaba to develop AI features for iPhones in China. This news immediately caught my attention, so I started looking for ways to benefit from it.

Date: 5.2.2025
AMD Slips After Earnings Report

For us investors following the semiconductor sector, today was very significant. AMD announced its results for the fourth quarter of 2024, beating expectations in terms of both sales and profit. Nevertheless, the shares fell by more than 9% after the end of regular trading hours.* This decline subsequently raised questions that I also dealt with. Is this an overreaction of the market, or is it a legitimate warning sign?

Date: 29.1.2025
ASML Exceeds Expectations: A Buying Opportunity?

Today's trading day was very interesting for me as I focused on the results of ASML, a leading player in chip manufacturing equipment, which published its results for the fourth quarter. ASML reported orders worth €7.09 billion, well above expectations. This order intake is a significant indicator that the demand for advanced equipment, driven by the growth of the AI field, remains strong.

Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.